Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

899 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adult acute myeloid leukemia.
Jabbour EJ, Estey E, Kantarjian HM. Jabbour EJ, et al. Mayo Clin Proc. 2006 Feb;81(2):247-60. doi: 10.4065/81.2.247. Mayo Clin Proc. 2006. PMID: 16471082 Review.
Phase I/II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome.
de Lima M, Champlin RE, Thall PF, Wang X, Martin TG 3rd, Cook JD, McCormick G, Qazilbash M, Kebriaei P, Couriel D, Shpall EJ, Khouri I, Anderlini P, Hosing C, Chan KW, Andersson BS, Patah PA, Caldera Z, Jabbour E, Giralt S. de Lima M, et al. Among authors: jabbour e. Leukemia. 2008 Feb;22(2):258-64. doi: 10.1038/sj.leu.2405014. Epub 2007 Nov 8. Leukemia. 2008. PMID: 17989720 Clinical Trial.
Targeted therapy in chronic myeloid leukemia.
Jabbour E, Cortes JE, Ghanem H, O'Brien S, Kantarjian HM. Jabbour E, et al. Expert Rev Anticancer Ther. 2008 Jan;8(1):99-110. doi: 10.1586/14737140.8.1.99. Expert Rev Anticancer Ther. 2008. PMID: 18095887 Review.
899 results